Tigermed's global team of experts has extensive experience in a wide range of therapeutic areas. Through our comprehensive one-stop service, we can provide you with professional clinical trial services.
Location: China, Zhejiang, Hangzhou
Employees: 5001-10000
Founded date: 2004
Investors 2
| Date | Name | Website |
| - | Qiming Ven... | qimingvent... |
| - | Qiming Ven... | qimingvc.c... |
Mentions in press and media 9
| Date | Title | Description |
| 30.11.2025 | Qiming Venture Partners Donates HK$3 Million to Tai Po Wang Fuk Court Aid Fund for Post-Fire Recovery | SHANGHAI, Nov. 30, 2025 /PRNewswire/ -- On the afternoon of November 26, a major Grade 5 fire spread across multiple residential buildings in Wang Fuk Court in Tai Po, Hong Kong, causing severe casualties and drawing widespread public conce... |
| 30.06.2025 | Qiming Venture Partners' Portfolio Company Unisound Successfully Lists on the Hong Kong Stock Exchange | SHANGHAI, June 30, 2025 /PRNewswire/ -- On June 30th, Beijing time, Unisound, a pioneer in the industrialization of AI technologies in China and a portfolio company of Qiming Venture Partners, has successfully debuted on the Hong Kong Stock... |
| 27.01.2025 | Qiming Venture Partners' Portfolio Company HyperStrong Successfully Listed on STAR Market | SHANGHAI, Jan. 27, 2025 /PRNewswire/ -- On January 27th, 2025, Beijing Time, Qiming Venture Partners' portfolio company HyperStrong, a leading provider of battery energy storage systems (BESS) in China, successfully debuted on the Shanghai ... |
| 29.08.2024 | DPC Dash Ltd: A Slice of Success in the Chinese Pizza Market | DPC Dash Ltd, the exclusive master franchisee of Domino's Pizza in mainland China, Hong Kong, and Macau, has recently unveiled its interim financial results for the first half of 2024. The numbers tell a compelling story of growth, resilien... |
| 28.08.2024 | Tigermed Reports 2024 Interim Results | HANGZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecyc... |
| 28.08.2024 | Tigermed Reports 2024 Interim Results | HANGZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecyc... |
| 30.05.2024 | Tigermed Advances Clinical Data Management with Veeva Vault EDC | Modern EDC streamlines key processes to accelerate study builds and make mid-study amendments with no downtime SHANGHAI, May 30, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV), the global leader in cloud solutions for the life sciences ind... |
| 25.08.2021 | Hangzhou Tigermed Consulting Co., Ltd announces an Equity Buyback for CNY 500 million worth of its shares. | Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) announces a share repurchase program. Under the program, the company will repurchase up to CNY 500 million worth of class A shares. The shares will be repurchased at a maximum price of CNY... |
| 17.07.2020 | China's CRO powerhouse Tigermed to seek $1B IPO in Hong Kong — report | Hong Kong’s effervescent biopharma IPO market could see its biggest debut of the year yet. Hangzhou Tigermed, a clinical research service provider that also invests in biotech companies, has been approved for a listing on t... |